1. Association of sulphonylurea treatment with all-cause and cardiovascular mortality: A systematic review and meta-analysis of observational studies. (July 2013) Authors: Forst, Thomas; Hanefeld, Markolf; Jacob, Stephan; Moeser, Guido; Schwenk, Gero; Pfützner, Andreas; Haupt, Axel Journal: Diabetes & vascular disease research Issue: Volume 10:Number 4(2013) Page Start: 302 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. GW24-e3085 The dual PPAR alpha/gamma agonist aleglitazar has a beneficial effect on atherogenic dyslipidemia in patients with type 2 diabetes. (1st October 2013) Authors: Herz, Matthias; Malmberg, Klas; Hanefeld, Markolf; Michael Lincoff, A; Mudie, Nadejda; Nicholls, Stephen Journal: Heart Issue: Volume 99(2013)Supplement 3 Page Start: A248 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗